Page 1 of 1
Loading...
Page 1 of 1
The COVID-19 pandemic has had a varying nature of impact on the fetal bovine serum (FBS) market in Australia and New Zealand for the year 2020 and 2021. For instance, the industries ...
The global influenza vaccine market size was valued at $5024.60 million in 2020, and is projected to reach $10,127.0 million by 2030, registering a CAGR of 7.20% from 2021 to 2030. The ...
The global pneumonia therapeutics market size was valued at $12,293.9 million in 2020, and is projected to reach $25,546.8 million by 2030, registering a CAGR of 8.5% from 2021 to 2030. Pneumonia ...
The global animal vaccines market size was valued at $9,093.9 million in 2020, and is projected to reach $15,201.5 million by 2030, registering a CAGR of 5.2% from 2021 to 2030. Animal ...
The global novel vaccine delivery systems market size was valued at $5,030 million in 2020 and is projected to reach $14,437 million by 2030 registering a CAGR of 10.8% from 2021 to 2030.
The global vaccine market size accounted for $32,462 million in 2019, and is expected to reach $54,168 million by 2027, registering a CAGR of 6.6% from 2020 to 2027.
The North America liver disease treatment market accounted for $6,970 million in 2019, and is expected to reach $8,318 million by 2027, registering a CAGR of 5.2% from 2020 to 2027.
The global cancer vaccines market was valued at $4,188 million in 2019, and is projected to reach $7,303 million by 2027, registering a CAGR of 12.6% from 2020 to 2027.
The veterinary medicine market accounted for $22,973 million in 2019, and is expected to reach $29,698 million by 2027, registering a CAGR of 4.6% from 2020 to 2027.
The diphtheria, pertussis, and tetanus (DTP) vaccine market was valued at $ 4,758.8 million in 2019, and is expected to reach $ 7,054.4 million by 2027, with a CAGR of 5.1%, during the forecast period.
The global meningococcal vaccine market size was valued at $1,935.5 million in 2018, and is projected to reach $4,192.6 million by 2026, registering a CAGR of 9.5% from 2019 to 2026. Invasive ...
The global influenza treatment market size accounted for $861.50 million in 2018, and is expected to reach $1,225.20 million by 2026, registering a CAGR of 4.5% from 2019 to 2026.
The global prostate cancer treatment market size was valued at $6,887 million in 2018, and is projected to reach $9,904 million by 2026, registering a CAGR of 4.6% from 2019 to 2026.
The global varicella live vaccine market was valued at $2,714 million in 2018, and is expected to reach $4,222 million by 2026, registering a CAGR of 5.7% from 2019 to 2026.
Global Needle-Free Injection Systems Market was valued at $8,166 million in 2016, and is estimated to reach $23,116 million by 2023, growing at a CAGR of 16.0% from 2017 to 2023. Needle-free ...
Various bacteria and microorganisms can enter the body to for a new infection via various mucosal sites. There is a huge amount of vaccines licensed at the moment that are parenterally administered. ...
Foot and mouth disease (FMD) is a severe, extremely contagious viral disease of the livestock that has a significant economic impact. It affects swine, cattle, sheep, goats, and other cloven-hoofed ruminants. Intensively ...
The swine flu vaccine is used to prevent the spread of H1N1 influenza that started as a pandemic in the year 2009. Swine flu is a respiratory disease caused by the influenza ...
Avian influenza is a disease caused by bird flu type A virus, which is found in aquatic birds and subsequently causes infection in domestic poultry. The virus was first detected in China. ...
Dengue is a mosquito-borne infectious disease that affects both animals and humans, it is caused by the dengue virus that belongs to the family of Flaviviridae and genus Flavivirus.
Page 1 of 1
There might be something that we haven’t covered in the scope and if it is as per your specific areas of interest, we can anytime customise and incorporate your requirements in the framework of the study and provide you with a customised report based on your exact needs.